Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Nov 1, 2024 | 0.21 | -3.11 |
T-Mobile US | TMUS | Nov 1, 2024 | 223.28 | +0.05 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Nov 1, 2024 | 40.03 | +0.63 |
T. Rowe Price Dividend Growth ETF | TDVG | Nov 1, 2024 | 39.86 | +0.15 |
T. Rowe Price Equity Income ETF | TEQI | Nov 1, 2024 | 41.34 | -0.18 |
T. Rowe Price Group | TROW | Nov 1, 2024 | 112.06 | +2.00 |
T. Rowe Price Growth Stock ETF | TGRW | Nov 1, 2024 | 37.87 | +0.83 |
T2 Biosystems | TTOO | Nov 1, 2024 | 0.85 | -2.85 |
Taboola.com | TBLA | Nov 1, 2024 | 3.34 | +0.60 |
Tactile Systems Technology | TCMD | Nov 1, 2024 | 14.69 | +1.24 |
Taitron Components A | TAIT | Nov 1, 2024 | 2.82 | 0.00 |
Taiwan Fund | TWN | Nov 1, 2024 | 44.26 | +2.10 |
Taiwan Index MSCI Ishares | EWT | Nov 1, 2024 | 54.80 | +1.07 |
Taiwan Semiconductor Manufacturing ADR | TSM | Nov 1, 2024 | 192.95 | +1.26 |
Take-Two Interactive Software | TTWO | Nov 1, 2024 | 163.78 | +1.27 |
Takeda Pharmaceutical ADR | TAK | Nov 1, 2024 | 13.96 | +0.14 |
TAL Education Group ADR | TAL | Nov 1, 2024 | 11.02 | -0.90 |
Talen Energy | TLN | Nov 1, 2024 | 173.88 | -4.12 |
Talis Biomedical | TLIS | Nov 1, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Nov 1, 2024 | 3.14 | +0.32 |
Talos Energy | TALO | Nov 1, 2024 | 10.08 | -1.37 |
Talphera | TLPH | Nov 1, 2024 | 0.92 | -1.97 |
Tamboran Resources | TBN | Nov 1, 2024 | 18.69 | -0.32 |
Tandem Diabetes Care | TNDM | Nov 1, 2024 | 31.91 | +1.72 |
Tanger | SKT | Nov 1, 2024 | 33.19 | -0.12 |
Tango Therapeutics | TNGX | Nov 1, 2024 | 5.15 | -5.24 |
Tantech | TANH | Nov 1, 2024 | 0.14 | +2.03 |
Taoping | TAOP | Nov 1, 2024 | 0.42 | -1.61 |
Tapestry | TPR | Nov 1, 2024 | 46.97 | -1.01 |
Targa Resources | TRGP | Nov 1, 2024 | 165.27 | -1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.